In The News
Aristocrat gets another shot at Lightning Link patent after ‘novel’ split High Court decision
World Touring Melbourne wins $2.8M over concert cancelled during COVID pandemic
Thresholds unveiled for ACCC review under new merger laws
Flex commission class action pleadings ‘inappropriate and unhelpful’, says judge
Former EY partner hit with indemnity costs for rejecting National Tiles settlement offer
Funder’s payout in AMP class action should be shaved by $2.6M, court told
Contingency fee rates may rise in wake of Slater & Gordon win
Carnival denies Ruby Princess passenger had ‘horrible’ time on ill-fated cruise
Seven says 13 women have made complaints about sacked journalist
Legal recruiter told employee it was not her job to ‘worry about the gender pay gap’, suit claims
Please login to bookmarkClose

Indian generic drug maker Cipla has sued pharmaceutical giants Bristol-Myers Squibb and Pfizer alleging the patents behind their blockbuster deep vein thrombosis drug Eliquis are invalid.

Subscribe for instant access to all Lawyerly content.

Already a subscriber?
Lost your password?

Contact us to enquire about group subscriptions.
error: The content is secured.

For information on rights and reprints, contact subscriptions@lawyerly.com.au